Cardiac Stem Cells can Repair Injured Heart

Cardiac Stem Cells can Repair Injured Heart

Dr. Kaushik Bharati
Medically Reviewed by The Medindia Medical Review Team on November 28, 2019 at 4:37 PM
Health In Focus
RSS Email Print This Page Comment bookmark
Font : A-A+

Highlights:
  • Cardiac stem cells can repair injured heart when injected directly into the heart tissue
  • The healing process is mediated by macrophages through an acute innate immune response
  • This results in significant improvement in healing of the injured heart
Injection of living or even dead cardiac stem cells into an injured heart generates an acute inflammatory response that leads to healing of the injured area and enhancement of the mechanical properties of the cardiac muscles, finds a new research from Cincinnati Children's Hospital Medical Center, USA.
Cardiac Stem Cells can Repair Injured Heart

The research team found that the inflammatory response is mediated by macrophages and the healing process led to an improvement in cardiac function, following a heart attack.

Show Full Article


The study, published in Nature, clearly showed that the underlying process by which stem cells heal the injured heart is entirely different from the initial proposal that stem cells replaced damaged or dead cardiac cells. Therefore, the study findings bring about a paradigm shift in the way cardiac stem cells function during the healing process of the injured heart. 

Study Team

The study was led by Dr. Jeffery D. Molkentin, PhD, who is the Principal Investigator and Director of the Molecular Cardiovascular Microbiology Laboratory at Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. He is also a Professor at the Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. The first author of the paper was Dr. Ronald J. Vagnozzi, PhD, who is a Fellow and Investigator in Molkentin's laboratory.  

Study Background

The present study is based on previous work published in Nature in 2014 by Molkentin's group, which showed that injection of c-KIT (CD117) positive cardiac stem cells into a damaged heart was incapable of regenerating the heart muscle cells or cardiomyocytes. Therefore, there was a need to "re-evaluate the current planned cell therapy-based clinical trials to ask how this therapy might really work," explains Molkentin.

Salient Features of the Study

  • The following two types of stem cells were used in the study:
  • An inert chemical called zymosan that induces an innate immune response was also used in the study
  • Injection of dead cells or zymosan also stimulated the healing process in the damaged heart tissue, much like the stem cells
  • Stem cell or zymosan therapies altered cellular immunity that led to decreased extracellular matrix connective tissue formation at the site of injury
  • Stem cell or zymosan therapies also improved the mechanical properties of the scar tissue
  • Zymosan therapy conferred slightly better and longer-lasting health benefits than an injection of stem cells or dead cells
  • Stem cells or zymosan need to be injected directly into the heart tissue around the site of injury caused by myocardial infarction (heart attack)
In this regard, Molkentin explains: "Most of the current trials were also incorrectly designed because they infuse cells into the vasculature." He adds: "Our results show that the injected material has to go directly into the heart tissue flanking the infarct region. This is where the healing is occurring and where the macrophages can work their magic."

Future Plans

The research team is planning to find ways to modulate the functionality of the cardiac stem cells to accelerate the healing process. This could lead to the development of improved stem cell-based therapies for heart disease in the future.

Concluding Remarks

"The innate immune response acutely altered cellular activity around the injured area of the heart so that it healed with a more optimized scar and improved contractile properties," Molkentin says. "The implications of our study are very straightforward and present important new evidence about an unsettled debate in the field of cardiovascular medicine."

Funding Source

The study was funded by the National Institutes of Health (NIH), the National Heart, Lung, and Blood Institute, the Howard Hughes Medical Institute, and the American Heart Association, USA.

Reference :
  1. An Acute Immune Response Underlies the Benefit of Cardiac Stem-cell Therapy - (https://www.nature.com/articles/s41586-019-1802-2)


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive